P1048 NUCLEOS(T)IDE ANALOGUE (NA) THERAPY FOR PERSONS IN THE IMMUNOTOLERANT PHASE OF CHB IS ASSOCIATED WITH SIGNIFICANT DECLINE IN HBeAg AND HBsAg LEVELS